Table 3

Distribution of prescribed antibiotics according to class in four selected diagnoses groups at one teaching and one mon-teaching hospital in Ujjain, India

Cardiovascular with no registered bacterial infection Subgroup 1Cardiovascular with suspected bacterial infection Subgroup 2Malaria or viral fever with no registered bacterial infection Subgroup 3Malaria or viral fever with suspected bacterial infection Subgroup 4
THNTHp ValueTHNTHp ValueTHNTHp ValueTHNTHp Value
Name of AB; ATC coden (%)n (%)n (%)n (%)n (%)n (%)n (%)n (%)
Total prescriptions27413366238885532103451316128
Tetracyclines; J01A; J01AA284 (10)5 (0)<0.001243 (10)0 (0)553 (17)75 (2)<0.00183 (26)0 (0)
β-Lactam ABs, penicillin; J01C456 (17)498 (15)0.041622 (26)184 (22)0.009111 (3)245 (7)<0.00112 (4)7 (5)0.431
 Extended-spectrum penicillins; J01CA83 (3)99 (3)0.843122 (5)99 (12)<0.00119 (1)51 (1)<0.0010 (0)2 (2)
 Combination of penicillin including β-lactamase AB; J01CR373 (14)399 (12)0.040500 (21)85 (10)<0.00192 (3)194 (6)<0.00112 (4)5 (4)1.0†
Other β-lactams; J01D496 (18)1391 (41)<0.001353 (15)304 (36)<0.001665 (21)1792 (52)<0.00140 (13)39 (30)<0.001
 1st-generation cephalosporins; J01DB7 (0)16 (1)0.1630 (0)5 (1)0 (0)9 (0)0 (0)0 (0)
 2nd-generation cephalosporins; J01DC0 (0)98 (3)0 (0)27 (3)0 (0)168 (5)0 (0)0 (0)
 3rd-generation cephalosporins; J01DD481 (18)1254 (37)<0.001353 (15)272 (32)<0.001665 (21)1606 (47)<0.00140 (13)39 (30)<0.001
 4th-generation cephalosporins; J01DH8 (0)23 (1)0.0320 (0)0 (0)0 (0)9 (0)0 (0)0 (0)
Sulfonamide with timethoprim; J01E: J01EE8 (0)0 (0)18 (1)0 (0)8 (0)0 (0)0 (0)0 (0)
Macrolides, lincosamides; J01F16 (1)2 (0)<0.0014 (0)6 (1)0.02515 (0)7 (0)0.0603 (1)4 (3)0.110†
 Macrolides; J01FA12 (0)20.0024 (0)6 (1)15 (0)7 (0)3 (1)4 (3)
 Lincosamides; J01FF4 (0)0 (0)0 (0)0 (0)0 (0)0 (0)0 (0)0 (0)
Aminoglycoside; J01G: J01GB78 (3)73 (2)0.090149 (6)46 (5)0.36417 (1)60 (2)<0.00111 (3)9 (7)0.102
Quinolones; J01M: J01MA1031 (38)301 (9)<0.001731 (31)112 (13)<0.0011526 (48)464 (13)<0.001126 (40)37 (29)0.030
Fixed-dose combination of ABs; J01R: J01RA*12 (0)929 (28)<0.00131 (1)170 (20)<0.00134 (1)669 (19)<0.0016 (2)17 (13)<0.01
Other ABs; J01X167 (6)176 (5)0.145132 (6)30 (4)0.020149 (5)138 (4)0.19720 (6)15 (12)0.056
 Glycopetide ABs; J01XA15 (1)176 (5)<0.0010 (0)0 (0)0 (0)0 (0)0 (0)0 (0)
 Imidazole derivatives; J01XD152 (6)0 (0)132 (6)30 (4)0.020149 (5)137 (4)0.17620 (6)15 (12)0.056
 Other ABs; J01XX0 (0)0 (0)0 (0)0 (0)0 (0)1 (0)0 (0)0 (0)
Drugs for treatment of tuberculosis; J04A0 (0)0 (0)24 (1)0 (0)00 (0)0 (0)0 (0)
 Antibiotics; J04AB (treatment for tuberculosis)0 (0)0 (0)6 (0)0 (0)0 (0)0 (0)0 (0)0 (0)
 Hydrazides; J04AC0 (0)0 (0)6 (0)0 (0)0 (0)0 (0)0 (0)0 (0)
 Other drugs for treatment of tuberculosis; J04AK0 (0)0 (0)12 (1)0 (0)0 (0)0 (0)0 (0)0 (0)
Nitroimidazole derivatives; P01AB (oral metronidazole)201 (7)0 (0)81 (3)3 (0)<0.001132 (4)1 (0)<0.00115 (5)0 (0)
  • Significant p values shown in bold.

  • Pearson χ2 and

  • †Fisher’s exact test was used to compare antibiotic prescribing details.

  • AB, antibiotics; ATC, Anatomical Therapeutic Chemical (classification); J01RA*, ATC code as assigned by Sharma et al.17 n (%), number of prescriptions (percentage in antibiotic class); NTH, non-teaching hospital; TH, teaching hospital.